Skip to content


Paricalcitol, Zemplar (paricalcitol) is a small molecule pharmaceutical. Paricalcitol was first approved as Paricalcitol on 1998-04-17. It is used to treat hyperparathyroidism in the USA. The pharmaceutical is active against vitamin D3 receptor.
Trade Name Paricalcitol, Zemplar
Common Name Paricalcitol
Indication hyperparathyroidism
Drug Class Vitamin D analogues
Get full access now